Saudi Kayan Petrochemical Valuation
Is 2350 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2350 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2350 (SAR7.55) is trading below our estimate of fair value (SAR27.01)
Significantly Below Fair Value: 2350 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2350?
Other financial metrics that can be useful for relative valuation.
| What is 2350's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.3x |
| Enterprise Value/EBITDA | 16.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2350's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.1x | ||
2330 Advanced Petrochemical | 4.3x | 48.3% | ر.س9.3b |
2310 Sahara International Petrochemical | 2.6x | 5.3% | ر.س18.8b |
2290 Yanbu National Petrochemical | 3.6x | 6.8% | ر.س22.2b |
2060 National Industrialization | 1.9x | 2.3% | ر.س7.3b |
2350 Saudi Kayan Petrochemical | 1.3x | 6.7% | ر.س11.3b |
Price-To-Sales vs Peers: 2350 is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (3.1x).
Price to Earnings Ratio vs Industry
How does 2350's PE Ratio compare vs other companies in the Asian Chemicals Industry?
Price-To-Sales vs Industry: 2350 is good value based on its Price-To-Sales Ratio (1.3x) compared to the Asian Chemicals industry average (1.5x).
Price to Sales Ratio vs Fair Ratio
What is 2350's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.3x |
| Fair PS Ratio | 1.3x |
Price-To-Sales vs Fair Ratio: 2350 is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | ر.س7.55 | ر.س9.41 +24.7% | 20.4% | ر.س13.80 | ر.س7.30 | n/a | 9 |
| Nov ’25 | ر.س7.78 | ر.س9.70 +24.7% | 20.1% | ر.س13.80 | ر.س7.50 | n/a | 10 |
| Oct ’25 | ر.س8.26 | ر.س10.02 +21.3% | 18.5% | ر.س13.80 | ر.س8.00 | n/a | 10 |
| Sep ’25 | ر.س8.51 | ر.س10.02 +17.7% | 18.5% | ر.س13.80 | ر.س8.00 | n/a | 10 |
| Aug ’25 | ر.س8.16 | ر.س10.35 +26.8% | 17.7% | ر.س13.80 | ر.س8.00 | n/a | 10 |
| Jul ’25 | ر.س8.05 | ر.س10.48 +30.2% | 16.1% | ر.س13.80 | ر.س8.00 | n/a | 10 |
| Jun ’25 | ر.س7.97 | ر.س10.63 +33.4% | 14.3% | ر.س13.80 | ر.س8.50 | n/a | 10 |
| May ’25 | ر.س9.28 | ر.س10.63 +14.5% | 14.3% | ر.س13.80 | ر.س8.50 | n/a | 10 |
| Apr ’25 | ر.س9.50 | ر.س11.47 +20.7% | 18.9% | ر.س16.70 | ر.س9.00 | n/a | 10 |
| Mar ’25 | ر.س9.65 | ر.س11.49 +19.1% | 18.7% | ر.س16.70 | ر.س9.00 | n/a | 10 |
| Feb ’25 | ر.س9.12 | ر.س12.00 +31.6% | 18.3% | ر.س16.70 | ر.س9.00 | n/a | 9 |
| Jan ’25 | ر.س10.96 | ر.س12.73 +16.2% | 17.8% | ر.س16.70 | ر.س9.50 | n/a | 9 |
| Dec ’24 | ر.س11.32 | ر.س12.92 +14.2% | 16.5% | ر.س16.70 | ر.س9.50 | n/a | 9 |
| Nov ’24 | ر.س10.46 | ر.س13.29 +27.0% | 14.5% | ر.س16.70 | ر.س10.70 | ر.س7.78 | 9 |
| Oct ’24 | ر.س12.50 | ر.س13.57 +8.5% | 14.4% | ر.س16.70 | ر.س10.70 | ر.س8.26 | 9 |
| Sep ’24 | ر.س12.18 | ر.س13.36 +9.7% | 12.1% | ر.س15.00 | ر.س11.00 | ر.س8.51 | 9 |
| Aug ’24 | ر.س12.04 | ر.س13.61 +13.0% | 13.0% | ر.س16.20 | ر.س11.00 | ر.س8.16 | 9 |
| Jul ’24 | n/a | ر.س13.55 0% | 14.0% | ر.س16.20 | ر.س11.00 | ر.س8.05 | 8 |
| Jun ’24 | ر.س13.14 | ر.س13.54 +3.0% | 14.1% | ر.س16.20 | ر.س11.00 | ر.س7.97 | 8 |
| May ’24 | ر.س12.62 | ر.س13.69 +8.5% | 13.5% | ر.س16.60 | ر.س11.20 | ر.س9.28 | 9 |
| Apr ’24 | ر.س12.10 | ر.س13.56 +12.0% | 12.5% | ر.س16.60 | ر.س11.20 | ر.س9.50 | 9 |
| Mar ’24 | ر.س12.70 | ر.س13.98 +10.0% | 12.6% | ر.س16.60 | ر.س11.20 | ر.س9.65 | 8 |
| Feb ’24 | ر.س13.08 | ر.س13.98 +6.8% | 12.6% | ر.س16.60 | ر.س11.20 | ر.س9.12 | 8 |
| Jan ’24 | ر.س13.76 | ر.س15.19 +10.4% | 13.3% | ر.س18.00 | ر.س11.20 | ر.س10.96 | 8 |
| Dec ’23 | ر.س12.00 | ر.س15.11 +25.9% | 14.5% | ر.س18.00 | ر.س11.80 | ر.س11.32 | 8 |
| Nov ’23 | ر.س12.74 | ر.س15.16 +19.0% | 14.0% | ر.س18.00 | ر.س12.00 | ر.س10.46 | 8 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.